Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia. [electronic resource]
- International journal of hematology Feb 2020
- 303-310 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
1865-3774
10.1007/s12185-019-02771-2 doi
Adolescent Asian People B-Lymphocytes Child Child, Preschool Humans Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy Receptors, Antigen, T-Cell--therapeutic use Recurrence Remission Induction Safety Treatment Outcome Young Adult